BEST PRACTICES FOR TREATING PAIN WITH OPIOID ANALGESICS
Choose the best possible answer for each question and mark your answers on the self-assessment answer sheet at the end of this book. There is a required score of 70% or better to receive a certificate of completion.
11. What is one way to reduce the stigma for patients living with chronic pain? A. Counseling patients in whom opioids are indicated that opioids are appropriate for them. B. Urging patients to self-manage moderate-to-severe pain. C. Optimizing use of non-steroidal anti-inflammatory drugs. D. Ensuring that individuals from minoritized racial and ethnic backgrounds have greater access to opioid therapy. 12. Gabapentin has mild-to-moderate benefit in the treatment of: A. Insomnia that commonly accompanies chronic pain. B. Short-term inflammation associated with acute pain caused by injury or surgery. C. Muscle spasm in low-back pain as an alternative to more sedating medications. D. Neuropathic pain syndromes. 13. Spinal manipulation has demonstrated improvements in pain and function when used: A. In combination with opioids in pain lasting longer than 3 months. B. For chronic tension headache. C. For fibromyalgia. D. In patients with chronic neck pain and concomitant opioid-use disorder (OUD). 14. Which is a true statement about factors to record in the patient record? A. Psychological and social factors should be included as these can contribute to the pain experience. B. Objective clinical markers for pain must be present before pain treatment is given. C. The primary objective of pain treatment is to document a reduction in the patient’s self-reported pain scale number. D. Diagnosis of chronic pain is made if pain is continuous.
15. Which of the following tools assess pain, pain interference, functional components, and quality of life, and was created to assess management of chronic pain in primary care settings? A. McGill Pain Questionnaire (MPQ). B. Pain, Enjoyment of Life, and General Activity Scale (PEG). C. Revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). D. The Visual Analogue Scale (VAS) combined with the Numerical Rating Scale (NRS). 16. Which is a true statement about screening patients for potential opioid misuse? A. Only the Drug Abuse Screening Test has been associated with a high degree of predictive accuracy. B. Brief screening tools are regarded to have clinical utility in diagnosing OUD. C. Single screening questions may be used. D. There is no evidence to support screening for risk ahead of opioid prescription. 17. Patients who are already being prescribed opioids for chronic pain who exhibit an active OUD should be: A. Discontinued immediately from opioids and treated with nonpharmacologic pain therapies. B. Engaged in collaborative taper and treated or referred for treatment with medications to manage OUD. C. Tapered rapidly from opioid doses and encouraged to seek psychiatric counseling. D. Rotated to a dual-mechanism opioid with less misuse potential and sent for detoxification from high-dose opioids.
46
Powered by FlippingBook